A critical investigation has shown that activation of endogenous TP53 downregulates the MVA pathway in human SK-HEP-1 hepatocellular carcinoma cells, HCT116 colon cancer cells, and mouse embryonic fibroblasts (MEFs) [28]. Here, TP53 is linked to hepatocellular carcinoma.